跳至主要内容
临床试验/NCT04992923
NCT04992923招募中不适用

Prospective Cohort Study of Patients With Infective Endocarditis Admitted at Cardiology Institute of Pitié-Salpêtrière Hospital

Assistance Publique - Hôpitaux de Paris1 个研究点 分布在 1 个国家目标入组 700 人开始时间: 2020年9月15日最近更新:
适应症

试验速览

阶段
不适用
状态
招募中
入组人数
700
试验地点
1
主要终点
All-cause in hospital mortality

研究概览

简要总结

Infective endocarditis (IE) is a severe condition associated with high mortality. Due to the relative low prevalence of IE, prospective data are lacking and current guidelines are mostly based on expert consensus with low level of evidence. IE is also associated with severe complications especially strokes that occur in about one third of the patients.

In order to improve the management and the prognosis of IE, clinical data from larges prospective cohort studies are needed.

详细描述

The study will take place at the Cardiology institute of the Pitié-Salpêtrière hospital. All patients referred to this tertiary care center for IE management will be included.

The characteristics of the patients (demographics, clinical, laboratory, and imaging data) at the time of IE diagnosis and during the follow-up will be collected. The patients will be followed up to 10 years after inclusion.

研究设计

研究类型
Observational
观察模型
Cohort
时间视角
Prospective

入排标准

年龄范围
18 Years 至 —(Adult, Older Adult)
性别
All
接受健康志愿者

入选标准

  • Patients with confirmed IE according to European Society of Cardiology criteria

排除标准

  • Opposition of the patient to participate

结局指标

主要结局

All-cause in hospital mortality

时间窗: up to 90 days

All-cause mortality during the length of hospital stay

次要结局

  • symptomatic or asymptomatic systemic embolism(up to 90 days after inclusion)
  • Association between coagulation biomarkers (D-dimer, fibrin monomer, circulating anticoagulant, von Willebrandt factor (VWF) antigen level, von Willebrandt factor (VWF) activity) assessed at the inclusion and the presence of systemic embolism(up to 90 days after inclusion)
  • heart failure, intracranial hemorrhage, or false vascular aneurysm during hospitalization(up to 90 days after inclusion)
  • All-cause mortality(an average of 10 years)
  • composite criteria of stroke, Intracranial hemorrhage, hospitalization due to cardiovascular cause or IE recurrence(through study completion, an average of 10 years)
  • Occurrence of contrast-associated acute kidney injury during the length of hospital stay(up to 90 days after inclusion)
  • Stroke(90 days after inclusion)
  • Association between occurrence of systemic embolism and the composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score ≥ 3(1 year after inclusion)
  • composite criteria of all-cause mortality, stroke or intracranial hemorrhage, severe hemorrhage as defined by BARC score ≥ 3(through study completion, an average of 10 years)

研究者

申办方类型
Other
责任方
Sponsor

研究点 (1)

Loading locations...

相似试验